Pham T, Maillefert J-F, Hudry C, Kieffert P, Bourgeois P, Lechevalier D, Dougados M
René Descartes University, Cochin Hospital, Paris, France.
Osteoarthritis Cartilage. 2004 Jan;12(1):46-55. doi: 10.1016/j.joca.2003.08.011.
To compare the clinical effects of laterally wedged insoles and neutrally wedged insoles (used as control) in patients with medial femoro-tibial knee osteoarthritis.
24-month prospective randomized controlled study.
Outpatients with painful medial femoro-tibial knee osteoarthritis.
Patient's overall assessment of disease activity (5 grade scale), WOMAC index subscales and concomitant treatments.
Performed as an intention-to-treat analysis, with the last observation carried forward (LOCF). Main symptomatic criterion: Improvement in the patient's assessment of activity (defined as a reduction of one grade or more at the end of the study as compared to baseline, and no intra-articular injection or lavage during the 6 months previous to the last visit). Secondary criteria for assessment: (a) Changes in the WOMAC subscales at month 24, and (b) concomitant therapies (analgesics, NSAIDs and intra-articular injections or lavages). Structural criterion: Joint space width (JSW) at the narrowest point. Non-compliance was defined as intermittent or lack of insole fitting at two consecutive visits. Compliance within groups was compared by using a life table analysis technique (Log-Rank).
The baseline characteristics of the 156 recruited patients (41 males, 115 females, mean age 64.8 years) were not different in the 2 treatment groups. At year 2, there was no statistically significant difference between the 2 groups concerning the percentages of patients with improvement in both global assessment of disease activity and in WOMAC subscales (pain, stiffness, function). The number of days with NSAIDs intake was lower in the group with laterally wedged insoles than in the neutrally wedged group (71+/-173 days vs. 127+/-193 days, P=0.003, Mann-Whitney test). The mean joint space narrowing rate did not differ between the two groups: 0.21+/-0.59 mm/year in the laterally wedged group vs 0.12+/-0.32 mm/year in the neutrally wedged group. Compliance and tolerance were satisfactory. Compliance was different between the 2 groups at month 24, with a greater frequency of patients who wore insoles permanently in the laterally wedged insole group than in the other group (85.8% vs 71.9%, P=0.023).
This study failed to demonstrate a relevant symptomatic and/or structural effect of laterally-wedged insoles in medial femoro-tibial OA. However, the reduced NSAIDs intake and the better compliance in the treatment group are in favor of a beneficial effect of laterally-wedged insoles in medial femoro-tibial OA.
比较外侧楔形鞋垫与中性楔形鞋垫(作为对照)对股胫内侧膝骨关节炎患者的临床疗效。
为期24个月的前瞻性随机对照研究。
股胫内侧膝骨关节炎疼痛门诊患者。
患者对疾病活动的总体评估(5级量表)、WOMAC指数子量表及伴随治疗。
采用意向性分析,末次观察值结转(LOCF)。主要症状标准:患者对活动评估的改善(定义为研究结束时与基线相比等级降低一级或更多,且末次就诊前6个月内未进行关节内注射或灌洗)。次要评估标准:(a)24个月时WOMAC子量表的变化,以及(b)伴随治疗(镇痛药、非甾体抗炎药及关节内注射或灌洗)。结构标准:最窄点的关节间隙宽度(JSW)。不依从定义为连续两次就诊时间歇性或未佩戴鞋垫。采用寿命表分析技术(对数秩检验)比较组内依从性。
156例入选患者(41例男性,115例女性,平均年龄64.8岁)的基线特征在两个治疗组中无差异。在第2年,两组在疾病活动总体评估和WOMAC子量表(疼痛、僵硬、功能)改善患者百分比方面无统计学显著差异。外侧楔形鞋垫组服用非甾体抗炎药的天数低于中性楔形鞋垫组(71±173天对127±193天,P = 0.003,曼-惠特尼检验)。两组的平均关节间隙狭窄率无差异:外侧楔形鞋垫组为0.21±0.59mm/年,中性楔形鞋垫组为0.12±0.32mm/年。依从性和耐受性良好。在第24个月时两组的依从性不同,外侧楔形鞋垫组永久佩戴鞋垫的患者频率高于另一组(85.8%对71.9%,P = 0.023)。
本研究未能证明外侧楔形鞋垫对股胫内侧骨关节炎有显著的症状和/或结构影响。然而,治疗组非甾体抗炎药摄入量减少且依从性更好,表明外侧楔形鞋垫对股胫内侧骨关节炎有有益作用。